Stroke Temperature, Inflammation, and the Missing Mechanism

A recent stroke study found that early temperature rise in the first 24 hours is a strong predictor of poor outcome, but it did not fully explain what that rise means biologically. In our book, the same phenomenon can be understood as a sign that stroke healing has moved away from eureactive optimality and toward a more complicated, hyperreactive inflammatory course. 

What the article shows

The article demonstrates that a single admission temperature is not very useful, while a rise in temperature during the first day is much more informative for predicting 3-month outcome in both ischemic and hemorrhagic stroke. That is an important practical finding, because it supports repeated monitoring rather than reliance on one baseline measurement. The study also suggests that antipyretic treatment should be guided by dynamic temperature change rather than by admission temperature alone.

What the book adds

Our book proposes a deeper interpretation: stroke is not simply necrosis, but a special form of aseptic inflammation in which recovery depends on the balance between necrotic and reparative processes. When this balance is preserved, healing follows the eureactive path; when it is disturbed, healing becomes hyperreactive or hyporeactive and outcomes worsen. In this view, hyperthermia is not just a number on the chart — it can be part of the clinical expression of a disturbed inflammatory-healing process. 

What the authors missed

The article mentions inflammation, but only briefly and mainly in the introduction. It does not fully develop the causal chain that our book outlines: hyperthermia, hyperreactive stress, leukocyte activation, polymorphonuclear infiltration, accelerated destructive processes, and impaired scar formation in the stroke zone. Because of that, the article remains useful as a prognostic study, but incomplete as an explanation of stroke biology.

Why this matters for care

If hyperthermia is viewed only as a prognostic marker, clinicians may focus narrowly on temperature reduction. But if it is viewed as a sign of disturbed inflammatory optimality, then stroke management becomes broader: clinicians should also think about the quality of healing, the stage of disease, and whether the patient is moving along an optimal or non-optimal trajectory. That approach is more consistent with the principle of disease optimality described in our book. 

Conclusion

The article is valuable because it identifies early hyperthermia as a clinically meaningful marker in stroke. Our book goes further by explaining the mechanism behind that marker: stroke heals through inflammation, but only when the process remains balanced and eureactive; once it becomes hyperreactive, healing becomes complicated and outcomes worsen. So the article gives the signal, while the book gives the meaning. 

For authors, clinicians, and researchers in stroke, the next step is to study these mechanisms carefully and to integrate them into future diagnostic and treatment thinking, because a deeper understanding of inflammatory optimality may help improve stroke healing and patient outcomes. 

You can learn more by reading our e-book or listening to our audiobook

Mykola Iabluchanskyi together with Andriy Yabluchanskiy